Article: article from journal or magazin.
Nouvelles approches therapeutiques de l'hypertension arterielle. [New therapeutic approaches to arterial hypertension]
Schweizerische Medizinische Wochenschrift
Today two largely new approaches are available for the treatment of clinical hypertension. First, captopril, an orally active angiotensin converting enzyme inhibitor, makes possible chronic blockade of the renin-angiotensin system. This compound, given alone or in combination with a diuretic, normalizes the blood pressure of most hypertensive patients. Unfortunately, because captopril may induce serious adverse effects the use of this inhibitor must be restricted to patients with high blood pressure refractory to conventional antihypertensive drugs. Second, compounds such as verapamil and nifedipine are capable of producing a marked vasodilating effect by inhibiting the entry of calcium into the vascular smooth muscle cells. However, the role of calcium channel blockers in the treatment of hypertensive disease awaits more precise definition.
Angiotensin II/antagonists & inhibitorsBenzothiadiazinesCalcium/metabolismCalcium Channel Blockers/therapeutic useCaptopril/administration & dosage/adverse effects/pharmacology/therapeuticuseDiureticsDrug Therapy, CombinationHumansHyperkalemia/chemically inducedHypertension/*drug therapyNifedipine/therapeutic useRenin-Angiotensin System/drug effectsSodium/metabolismSodium Chloride Symporter Inhibitors/therapeutic useVasodilationVerapamil/therapeutic use
Web of science
Last modification date